Sana Kliniken AG implements Symptom Checker from Infermedica
We formed a partnership with Sana Kliniken, one of the largest German healthcare providers.
Company
Infermedica raises $10.25M in Series A funding
We are entering the next stage of growth. See how the new funds will accelerate the development of our AI-based solutions for healthcare.
Microsoft partners up with Infermedica
Infermedica provides technology to the Microsoft Healthcare Bot Service, empowering others to use AI-based virtual assistants at scale.
COVID-19 Risk Assessment ChatBot is ready to chat
Infermedica and LiveChat joined forces to create a chatbot to help in the fight against COVID-19. Explore the way patients are using it.
COVID-19 Risk Assessment tool is here
As the pandemic emerged, our team worked non-stop and released a free COVID-19 risk evaluation tool.
COVID-19 and Infermedica
COVID-19 is more than just a hot topic. Helping patients quickly assess their risk of coronavirus is how we are fighting this global crisis.
Infermedica 2019: Year in Review
2019 was a breakthrough. We've managed to grow our team, gain new clients, improve the product, and raise additional funding.
Infermedica raises $3.65M in a new round of funding
Our initial idea has turned into a bold mission to guide every patient to the best possible care, gaining new allies along the way.
Infermedica raises $10.25M in Series A funding
We are entering the next stage of growth. See how the new funds will accelerate the development of our AI-based solutions for healthcare.
Microsoft partners up with Infermedica
Infermedica provides technology to the Microsoft Healthcare Bot Service, empowering others to use AI-based virtual assistants at scale.
COVID-19 Risk Assessment ChatBot is ready to chat
Infermedica and LiveChat joined forces to create a chatbot to help in the fight against COVID-19. Explore the way patients are using it.
COVID-19 Risk Assessment tool is here
As the pandemic emerged, our team worked non-stop and released a free COVID-19 risk evaluation tool.
COVID-19 and Infermedica
COVID-19 is more than just a hot topic. Helping patients quickly assess their risk of coronavirus is how we are fighting this global crisis.
Infermedica 2019: Year in Review
2019 was a breakthrough. We've managed to grow our team, gain new clients, improve the product, and raise additional funding.
Infermedica raises $3.65M in a new round of funding
Our initial idea has turned into a bold mission to guide every patient to the best possible care, gaining new allies along the way.